期刊文献+

黄芪甲苷对人膝骨关节炎退变关节软骨VEGF表达的影响 被引量:5

Astragaloside IV Preventing Cartilage Degeneration of Patients with Knee Osteoarthritis by Adjusting VEGF mRNA Expression
原文传递
导出
摘要 目的:研究黄芪甲苷对人膝骨关节炎退变关节软骨VEGF表达的影响。方法:取人手术后的退变膝关节软骨,进行细胞培养,将培养的软骨细胞分离传代后,取第三代细胞,通过HE、Ⅱ型胶原免疫荧光染色进行软骨细胞鉴定,并进行VEGF免疫荧光染色。观察软骨细胞退变情况后分为6组(A组:软骨细胞+DMEM对照组;B组:软骨细胞+25mmol/L黄芪甲苷;C组:软骨细胞+50 mmol/L黄芪甲苷;D组:软骨细胞+75 mmol/L黄芪甲苷;E组:软骨细胞+100mmol/L黄芪甲苷;F组:软骨细胞+500 mmol/L黄芪甲苷),取4 h、8 h、24 h、48 h、72 h采用实时荧光定量聚合酶链式反应(PCR)检测各组退变软骨内VEGF表达mRN A的表达情况。结果:培养的细胞为退变的软骨细胞;实时荧光定量PCR结果显示,不同浓度黄芪甲苷有上调退变膝关节软骨细胞VEGF的作用,且75 mmol/L黄芪甲苷在48 h时上调作用最好;在24 h、48 h、72 h不同浓度(50~100 mmol/l)黄芪甲苷膝关节软骨细胞VEGF表达量高于对照组(F=21.304,P<0.001)。结论:黄芪甲苷可通过调节退变软骨细胞合成VEGF延缓膝骨关节炎关节软骨细胞的退变。 Objective : To investigate the effect of Astragaloside IV adjusting VEGF mRNA expression in chondrocyte of patients with knee osteoarthfitis. Methods:The cartilage of patients with knee osteoarthritis after operation was carried out and cell culture was made. When cells were more enough, and the third generation cells were given HE stain and fluoreseein stain with II - colla- gen to checkout whether they were the cartilage ceils. Then the third generation ceils were divided equally into six group( group A: cartilage cells + control group of DMEM ; group B : cartilage cells + concentration of AstragalosideIV was 25 mmol/L ; group C : car- tilage cells + concentration of AstragalosideIV was 50 mmol/L ; group D : cartilage cells + concentration of AstragalosideIV was 75 mmol/L;group E:cartilage cells + concentration of AstragalosideIV was 100 mmol/L;group F:eartilage cells + concentration of AstragalosideIV was 500 retool/L) ,at~ 4 h,8 h,24 h,48 h,72 h. Total RNA isolated from these samples was used for real - time PCR of VEGF. Results : Cultured cells were cheekouted cartilage cells. Real - time PCR showed concentration of Astragaloside IV at 50 ~ 100 mmol/L upregulated mRNA expression of VEGF. Conclusion:Astragaloside IV can prevents cartilage degeneration of patients with knee osteoarthritis.
出处 《辽宁中医杂志》 CAS 2013年第5期1043-1045,共3页 Liaoning Journal of Traditional Chinese Medicine
基金 江苏省中医药管理局计划项目(HZ07089)
关键词 膝骨关节炎 退变 黄芪甲苷 软骨细胞 VEGF knee osteoarthritis degeneration Astragaloside IV cartilage cell VEGF
  • 相关文献

参考文献8

  • 1胡志明,周明乾,高基民.VEGF与TNFR联合治疗股骨头坏死实验研究[J].南方医科大学学报,2008,28(12):2177-2179. 被引量:9
  • 2王开友,王颖,赵新刚,修晓光.VEGF治疗退变性膝关节炎的动物实验研究[J].齐鲁医学杂志,2009,24(5):434-436. 被引量:2
  • 3Bouis D,Kusumanto Y,Meijer C,et al.A review on pro-and anti-an-glo-genic factors as targets of clinical intervention[J].Pharmacol Res,2006,53:89-103.
  • 4刘威,赵印震,卢博.分期治疗膝关节骨性关节炎[J].四川中医,2007,25(8):91-92. 被引量:9
  • 5施杞 王和鸣 王拥军 等.骨性关节炎.中医骨伤科临床研究,2009,(1):318-319.
  • 6Kikuchi T,Nakamura T.Monocyte chemoattractant protein-1 in theintervertebral disc:A histological experimental model[J].Spine,1998,20(10):1091-1099.
  • 7Williams RS,Annex BH.Plasticity of myocytes and capilliaries a pos-sible corrdinating role for VEGF[J].Circ Res,2004,95(1):7-8.
  • 8北川勋.日本药学会第101次年会讲演要旨集[M].熊本:东京都涩谷,1981:504.

二级参考文献20

  • 1娄思权.骨关节炎的病理与发病因素[J].中华骨科杂志,1996,16(1):56-59. 被引量:232
  • 2胡志明,王海彬,李祖国,周斌,王小宁.TNFα和VEGF在激素性股骨头坏死中的变化[J].中国矫形外科杂志,2006,14(12):912-914. 被引量:18
  • 3邓念,范雪梅,刘永辉.得宝松联合施沛特治疗膝关节骨性关节炎的效果[J].齐鲁医学杂志,2006,21(6):495-496. 被引量:1
  • 4Bejar J, Peled E, Boss JH. Vasculature deprivation-induced osteonecrosis of the rat femoral head as a model for therapeutic trials[J]. Theor Biol Med Model, 2005, 24:1185-95.
  • 5Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis ofosteocytes in glucocorticoid-induced osteonecrosis of the hip[J].J Clin Endocrinol Metab, 2000, 85: 2907-12.
  • 6Murray KM, Dahl SL. Recombinant human tumor necrosis factor receptor (975) Fc fusion protein (TNFR: Fc) in rheumatoid arthritis [J]. Ann Pharmacother, 1997, 31(11): 1335-8.
  • 7Lu E, Wagner WR, Schellenberger U, et al. Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue[J].Circulation, 2003, 108 (1): 97-103.
  • 8Weidner N. Curred pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors[J].Breast Cancer Res Treat, 1995, 36: 169.
  • 9Schrezenmeir J, Gluer CC. The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model[J]. Bone, 2003, 33(6): 869-76.
  • 10Furumatsu T, Shen Z N, Kawai A, et al. Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis [J]. J Biochem, 2003, 133(5): 633-9.

共引文献18

同被引文献90

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部